Jiangsu Hengrui Medicine Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 13,297.542 million compared to CNY 11,308.881 million a year ago. Operating income was CNY 3,227.104 million compared to CNY 3,251.125 million a year ago. Net income was CNY 2,667.595 million compared to CNY 2,661.917 million a year ago. Basic earnings per share from continuing operations was CNY 0.42 compared to CNY 0.42 a year ago. Diluted earnings per share from continuing operations was CNY 0.42 compared to CNY 0.41 a year ago.